APA (7th ed.) Citation

LP, G., PA, R., V, N., LA, P., ME, M., SS, V., & SD, N. (2025). Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD. Journal of the American Society of Nephrology : JASN, 36(1), 87. https://doi.org/10.1681/ASN.0000000000000477

Chicago Style (17th ed.) Citation

LP, Gregg, Richardson PA, Nambi V, Petersen LA, Matheny ME, Virani SS, and Navaneethan SD. "Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD." Journal of the American Society of Nephrology : JASN 36, no. 1 (2025): 87. https://doi.org/10.1681/ASN.0000000000000477.

MLA (9th ed.) Citation

LP, Gregg, et al. "Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD." Journal of the American Society of Nephrology : JASN, vol. 36, no. 1, 2025, p. 87, https://doi.org/10.1681/ASN.0000000000000477.